Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Head Pain

In brief

Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department

Key facts

Study ID

NCT05325580

Run by

University of Monastir

People needed

424

Starts

2021-12-01

Expected to finish

2026-12-30

Last updated by the study team

2024-02-28

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• informed consent
• age >18 years
• Acute non-traumatic acute headaches
• patients treated in ED
• Magnesium sulfate and aspirin administered intravenously (IV)

You may not qualify if…

• Current regular use of analgesics, anticonvulsants or antidepressants
• Renal disorder with a low glomerular filtration rate (<60 ml/min)
• Neuromuscular disorder
• Pregnant woman
• Contrindication
• Allergy to NSAID
• Traumatic Headache
• Chronic headache ( headache occurring at least 15 days per month for at least 3 months)
• Hemodynamic instability

Where it is running

• University of Monasrtir — Monastir, Tunisia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.